Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Thyrocare Technologies Limited
  6. News
  7. Summary
    539871   INE594H01019

THYROCARE TECHNOLOGIES LIMITED

(539871)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Indian shares end lower as IT stocks and Reliance drag

06/28/2021 | 06:45am EDT

BENGALURU, June 28 (Reuters) - Indian shares closed lower on Monday, weighed down by heavyweight information technology stocks and Reliance Industries, with investors showing little reaction to relief measures announced by the country's finance minister.

Benchmark indices snapped their two-day winning streak with the blue-chip NSE Nifty 50 index ending 0.29% lower at 15,814.70, while the S&P BSE Sensex closed down 0.36% to end at 52,735.59.

Both the indexes added about 1.1% each last week, when over 41 million COVID-19 vaccine doses were administered across the country and some pandemic-induced restrictions were further eased.

However, the Nifty and Sensex struggled for momentum on Monday after hitting record highs when they opened, with investors largely looking past several relief measures announced by India's finance minister late in the session.

Global shares also dented sentiment as Asian and European markets fell after a spike in coronavirus cases across Asia over the weekend.

In Mumbai trading, the Nifty IT index ended 0.49% lower after two straight sessions of gains. The country's top software services provider Tata Consultancy Services fell 1.3% and was among the top percentage losers on the Nifty 50.

Billionaire Mukesh Ambani-owned conglomerate Reliance closed 0.7% lower, clocking its fifth consecutive day of losses.

The Nifty Pharma index ended up 1.27%, for only its fourth session of gains in eleven.

Thyrocare Technologies closed down 9.6% after hitting a record high on Friday. Temasek-backed online pharmacy PharmEasy's parent is set to buy a 66.1% stake in the medical laboratory chain owner.

Hospital chain operator Krishna Institute of Medical Sciences and milk distributor Dodla Dairy saw strong market debuts, gaining 20.8% and 42.5%, respectively.

(Reporting by Shivani Singh in Bengaluru; Editing by Krishna Chandra Eluri)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
RELIANCE INDUSTRIES LTD 0.07% 2478.5 Delayed Quote.25.42%
TATA CONSULTANCY SERVICES LTD. 0.25% 3877.8 Delayed Quote.35.16%
THYROCARE TECHNOLOGIES LIMITED -0.60% 1263 End-of-day quote.38.27%
All news about THYROCARE TECHNOLOGIES LIMITED
08/24Docon Technologies Private Limited completed the acquisition of 5.07% stake in Thyrocar..
CI
08/12Thyrocare Technologies Limited Announces Earnings Results for the First Quarter Ended J..
CI
06/28Indian shares end lower as IT stocks and Reliance drag
RE
06/28Indian shares end lower as IT stocks and Reliance drag
RE
06/28THYROCARE TECHNOLOGIES : Indian shares edge lower as tech losses outweigh gains in pharma
RE
06/25Docon Technologies Private Limited entered into a share purchase agreement to acquire 6..
CI
06/25Docon Technologies Private Limited announced an open offer to acquire 26% stake in Thyr..
CI
06/17Pharmeasy Looks to Acquire a Stake in Thyrocare
CI
05/19THYROCARE TECHNOLOGIES : Indian data suggests runaway COVID infections as deaths hit daily..
RE
05/09Thyrocare Technologies Limited Recommends Dividend
CI
More news
Financials
Sales 2022 6 041 M 82,0 M 82,0 M
Net income 2022 1 696 M 23,0 M 23,0 M
Net cash 2022 1 735 M 23,5 M 23,5 M
P/E ratio 2022 39,5x
Yield 2022 1,46%
Capitalization 66 780 M 905 M 906 M
EV / Sales 2022 10,8x
EV / Sales 2023 10,0x
Nbr of Employees 1 582
Free-Float 25,9%
Chart THYROCARE TECHNOLOGIES LIMITED
Duration : Period :
Thyrocare Technologies Limited Technical Analysis Chart | 539871 | INE594H01019 | MarketScreener
Technical analysis trends THYROCARE TECHNOLOGIES LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 1 263,00 INR
Average target price 1 293,75 INR
Spread / Average Target 2,43%
EPS Revisions
Managers and Directors
Arokiaswamy Velumani Chairman, Chief Executive Officer & MD
Sundararaju Aarogias Naidu Chief Financial Officer & Executive Director
Ceaser Sengupta Vice President-Operations
Ramjee Dorai Secretary, Compliance Officer & Head-Legal
Gopalkrishna Shivram Hegde Independent Non-Executive Director
Sector and Competitors